C. Dekker

C. Dekker

Finanzdirektor/CFO bei ARCA BIOPHARMA, INC.

Vermögen: 139 600 $ am 30.04.2024

60 Jahre
Technology Services
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von C. Dekker

EinheitArt der EinheitIndustrie
KPMG Peat Marwick LLP
38
Extinct Miscellaneous Commercial Services 38
Utah State University
30
College/University Other Consumer Services 30
Public Company Pharmaceuticals: Major 14
Public Company Pharmaceuticals: Other 10
7
Subsidiary Packaged Software 7
5
Subsidiary Packaged Software 5

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von C. Dekker

UnternehmenSektorVerknüpfte PersonenHauptposition
Medical Specialties

Thomas Keuer

Alan K. Smith

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

John H. Frenz

Debra Marshall

Corporate Officer/Principal

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

J. William Freytag

Kirk A. Christoffersen

Corporate Officer/Principal

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

S. Torres

Debra Marshall

Director of Finance/CFO

Corporate Officer/Principal

MICROSOFT CORPORATION Packaged Software

Paul Lipman

On Lee

Corporate Officer/Principal

Private Equity Investor

Biotechnology

Thomas Keuer

J. William Freytag

Chief Operating Officer

Corporate Officer/Principal

AMERITYRE CORPORATION Automotive Aftermarket

Kenneth C. Johnsen

Elliott N. Taylor

Director/Board Member

General Counsel

VERICEL CORPORATION Pharmaceuticals: Major

Alan K. Smith

Chief Tech/Sci/R&D Officer

Investment Managers

Paul Anthony Mieyal

Paul Jacobi

Portfolio Manager-Equities

Portfolio Manager-Equities

Pharmaceuticals: Major

Dan Mitchell

Michael Bristow

J. William Freytag

Brian L. Selby

Director/Board Member

Founder

Chief Executive Officer

Comptroller/Controller/Auditor

Pharmaceuticals: Major

Timothy C. Rodell

J. William Freytag

Founder

Director/Board Member

Information Technology Services

Kimberley Vogel

Director of Finance/CFO

Pharmaceuticals: Major

Paul Anthony Mieyal

Director/Board Member

BELLICUM PHARMACEUTICALS, INC. Biotechnology

Alan K. Smith

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Timothy C. Rodell

Robert Conway

Director/Board Member

Director/Board Member

Medical Specialties

Paul Anthony Mieyal

Director/Board Member

Miscellaneous Commercial Services

Maureen Anne O'Rourke

Michael Salvati

Corporate Officer/Principal

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Salvatore Gentile

Jacob Ma-Weaver

Masters Business Admin

Graduate Degree

Stanford University College/University

Paul Lipman

Christopher Ozeroff

Masters Business Admin

Undergraduate Degree

Miscellaneous Commercial Services

Josh Pace

Jonathon Bunker

Brian L. Selby

Corporate Officer/Principal

Comptroller/Controller/Auditor

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Danilo Cacciamatta

Michael Salvati

Joseph Catapano

Paul C. Hehn

Hui Tang

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Michigan College/University

Barbara J. Mowry

Jai Shah

Kirk A. Christoffersen

Susan Oakes

Corporate Officer/Principal

Masters Business Admin

Undergraduate Degree

Graduate Degree

Yale University College/University

Kenneth C. Johnsen

Pennina Safer

Linda Grais

John H. Frenz

Graduate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

University of Illinois College/University

Dan Mitchell

Michael Bristow

Michael Salvati

Undergraduate Degree

Doctorate Degree

Graduate Degree

The University of Colorado College/University

Josh Pace

Elissa A. Potucek

Christopher Ozeroff

Masters Business Admin

Undergraduate Degree

Corporate Officer/Principal

J. Reuben Clark Law School College/University

Justin Olsen

Matthew Miller

Graduate Degree

Graduate Degree

The University of North Carolina at Charlotte College/University

Josh Pace

Joel Bauman

Undergraduate Degree

Graduate Degree

Miscellaneous Commercial Services

Chung Man Lau

Hui Tang

Corporate Officer/Principal

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

John H. Frenz

James Flynn

Graduate Degree

Undergraduate Degree

College/University

Jeffrey Rona

Paul Anthony Mieyal

Undergraduate Degree

Undergraduate Degree

Georgetown University College/University

Jordan Welu

John Moriarty

Undergraduate Degree

Undergraduate Degree

Purdue University College/University

J. William Freytag

Thomas Golab

Undergraduate Degree

Undergraduate Degree

University of Utah College/University

Nader Z. Pourhassan

Jeffrey L. Kirk

Doctorate Degree

Undergraduate Degree

University of Denver College/University

Kathleen Cunningham

Yoshiaki Uematsu

Masters Business Admin

Undergraduate Degree

The Wharton School of the University of Pennsylvania College/University

Robert John Scott Roriston

Quinn J. Coburn

Masters Business Admin

Masters Business Admin

The University of Texas at Austin College/University

Thomas Keuer

Joel Bauman

Undergraduate Degree

Masters Business Admin

Southern Utah University College/University

Alan K. Smith

Undergraduate Degree

Harvard Business School College/University

Kimberley Vogel

Masters Business Admin

Medical/Nursing Services

Kimberley Vogel

Corporate Officer/Principal

AKOUOS Biotechnology

Alan K. Smith

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Alan K. Smith

Director/Board Member

New York Medical College College/University

Paul Anthony Mieyal

Doctorate Degree

Statistik

International

Vereinigte Staaten 48
Hong Kong 2

Sektoral

Consumer Services 19
Health Technology 16
Commercial Services 8
Finance 4
Technology Services 3

Operativ

Director/Board Member 299
Corporate Officer/Principal 234
Undergraduate Degree 92
Director of Finance/CFO 79
Independent Dir/Board Member 66
  1. Börse
  2. Insiders
  3. C. Dekker
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT